Efficacy, safety, and retention rate of extended-release divalproex versus conventional delayed-release divalproex: A protocol for systematic review and meta-analysis

BACKGROUND: A novel once-daily divalproex-extended release (VPA-ER) dose formulation has been developed, which prolongs therapeutic serum levels compared with that of twice-daily conventional divalproex-delayed release (VPA-DR). Currently, there is lack of meta-analysis focusing on drug retention ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen Qi, Bai, Xue Yang, Wan, Yong, Li, Hong Yan, Sun, Hongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678006/
https://www.ncbi.nlm.nih.gov/pubmed/34918705
http://dx.doi.org/10.1097/MD.0000000000028290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678006/
https://www.ncbi.nlm.nih.gov/pubmed/34918705
http://dx.doi.org/10.1097/MD.0000000000028290

Ejemplares similares